U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C24H31FN2
Molecular Weight 366.5147
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2F-MT-45

SMILES

FC1=C(C=CC=C1)C(CC2=CC=CC=C2)N3CCN(CC3)C4CCCCC4

InChI

InChIKey=BZESPHAKQKJBSM-UHFFFAOYSA-N
InChI=1S/C24H31FN2/c25-23-14-8-7-13-22(23)24(19-20-9-3-1-4-10-20)27-17-15-26(16-18-27)21-11-5-2-6-12-21/h1,3-4,7-10,13-14,21,24H,2,5-6,11-12,15-19H2

HIDE SMILES / InChI

Molecular Formula C24H31FN2
Molecular Weight 366.5147
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Substance Class Chemical
Created
by admin
on Fri Jul 07 00:04:15 UTC 2023
Edited
by admin
on Fri Jul 07 00:04:15 UTC 2023
Record UNII
B5PQ8A33Q9
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2F-MT-45
Code English
1-CYCLOHEXYL-4-(1-(2-FLUOROPHENYL)-2-PHENYL-ETHYL)PIPERAZINE
Systematic Name English
Code System Code Type Description
FDA UNII
B5PQ8A33Q9
Created by admin on Fri Jul 07 00:04:15 UTC 2023 , Edited by admin on Fri Jul 07 00:04:15 UTC 2023
PRIMARY
PUBCHEM
132990975
Created by admin on Fri Jul 07 00:04:15 UTC 2023 , Edited by admin on Fri Jul 07 00:04:15 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
β‐arrestin2 recruitment
EC50
TARGET -> AGONIST
The fluorinated MT‐45 derivatives have higher apparent potencies (2F‐MT‐45: 42 nM) than MT‐45 (1.3 μM) for inhibition of cAMP accumulation and β‐arrestin2 recruitment (2F‐MT‐45: 196 nM; MT‐45: 23.1 μM).
EC50
TARGET -> AGONIST
β‐arrestin2 recruitment
Related Record Type Details
ACTIVE MOIETY